Showing 133 to 144 of 623 results
Gold Price Surges to \$2,871.74 Amidst Rising Inflation
Gold prices hit \$2,871.74 per ounce this week, up nearly 40% since January 2024 due to rising inflation (2.9% in December) and investor demand for portfolio diversification and inflation hedging, prompting investment consideration.
Gold Price Surges to \$2,871.74 Amidst Rising Inflation
Gold prices hit \$2,871.74 per ounce this week, up nearly 40% since January 2024 due to rising inflation (2.9% in December) and investor demand for portfolio diversification and inflation hedging, prompting investment consideration.
Progress
56% Bias Score
Qualcomm Beats Q1 Estimates, but Q2 Outlook Dampened by Huawei Licensing Loss
Qualcomm's Q1 fiscal year 2025 results exceeded expectations, with $11.67 billion in sales and $3.41 in adjusted profit per share, exceeding analyst estimates. However, the company anticipates flat Q2 patent licensing revenue due to the end of its Huawei agreement, which analysts estimated contribut...
Qualcomm Beats Q1 Estimates, but Q2 Outlook Dampened by Huawei Licensing Loss
Qualcomm's Q1 fiscal year 2025 results exceeded expectations, with $11.67 billion in sales and $3.41 in adjusted profit per share, exceeding analyst estimates. However, the company anticipates flat Q2 patent licensing revenue due to the end of its Huawei agreement, which analysts estimated contribut...
Progress
32% Bias Score
Spotify Reports First Annual Profit, Shares Surge 10%
Spotify announced its first annual profit of €1.14 billion, exceeding expectations for fourth-quarter revenue (€4.24 billion vs. €4.19 billion expected) while slightly missing expectations for earnings per share (€1.76 vs. €1.99 expected), driven by a record 35 million net MAU growth in Q4.
Spotify Reports First Annual Profit, Shares Surge 10%
Spotify announced its first annual profit of €1.14 billion, exceeding expectations for fourth-quarter revenue (€4.24 billion vs. €4.19 billion expected) while slightly missing expectations for earnings per share (€1.76 vs. €1.99 expected), driven by a record 35 million net MAU growth in Q4.
Progress
24% Bias Score
Over One Million Britons Miss Tax Deadline, Facing £100 Fines
Over one million UK taxpayers missed the January 31st tax deadline, facing a £100 fine; 732,498 returns were filed on the last day, with 31,442 in the final hour, highlighting challenges in timely tax compliance.
Over One Million Britons Miss Tax Deadline, Facing £100 Fines
Over one million UK taxpayers missed the January 31st tax deadline, facing a £100 fine; 732,498 returns were filed on the last day, with 31,442 in the final hour, highlighting challenges in timely tax compliance.
Progress
40% Bias Score
Understanding TFSA Contribution Room and Investment Strategies
Withdrawing from a TFSA adds the amount to your contribution room the following January 1st, usable in any TFSA; however, CRA data is often outdated, causing potential overcontribution penalties (1% monthly tax on the excess); therefore, accurate personal record-keeping is essential for optimal TFSA...
Understanding TFSA Contribution Room and Investment Strategies
Withdrawing from a TFSA adds the amount to your contribution room the following January 1st, usable in any TFSA; however, CRA data is often outdated, causing potential overcontribution penalties (1% monthly tax on the excess); therefore, accurate personal record-keeping is essential for optimal TFSA...
Progress
32% Bias Score
Home Equity Loan Rates: A January 2024 Analysis
As of January 31st, the average home equity loan interest rate was 8.44%, almost three times lower than the average 23% credit card interest rate, due to home collateral. The Federal Reserve's paused rate cuts make further February decreases unlikely, but inflation drops could trigger lender rate re...
Home Equity Loan Rates: A January 2024 Analysis
As of January 31st, the average home equity loan interest rate was 8.44%, almost three times lower than the average 23% credit card interest rate, due to home collateral. The Federal Reserve's paused rate cuts make further February decreases unlikely, but inflation drops could trigger lender rate re...
Progress
48% Bias Score
Walgreens Sells $300M Cencora Stake to Fund Turnaround
Walgreens Boots Alliance sold its remaining 1.3 million shares of Cencora for approximately $300 million, reducing its stake from 10% to 6%, primarily to pay down debt and support a broader financial turnaround that includes closing more than 1200 stores and suspending quarterly dividend payments.
Walgreens Sells $300M Cencora Stake to Fund Turnaround
Walgreens Boots Alliance sold its remaining 1.3 million shares of Cencora for approximately $300 million, reducing its stake from 10% to 6%, primarily to pay down debt and support a broader financial turnaround that includes closing more than 1200 stores and suspending quarterly dividend payments.
Progress
36% Bias Score
FBI Nominee Patel's $2.6 Million in Income Raises Conflict of Interest Concerns
Donald Trump's FBI director nominee, Kash Patel, reported over $2.6 million in income last year from consulting, media appearances, and book deals, raising concerns about potential conflicts of interest given his past ties to the Trump administration and foreign entities.
FBI Nominee Patel's $2.6 Million in Income Raises Conflict of Interest Concerns
Donald Trump's FBI director nominee, Kash Patel, reported over $2.6 million in income last year from consulting, media appearances, and book deals, raising concerns about potential conflicts of interest given his past ties to the Trump administration and foreign entities.
Progress
36% Bias Score
CFPB Halted Amidst Billionaire-Fueled Backlash
Treasury Secretary Scott Bessent, under pressure from President Trump and tech billionaires including Elon Musk and Mark Zuckerberg who sought to limit the agency's power, ordered a halt to the Consumer Financial Protection Bureau's operations on Monday.
CFPB Halted Amidst Billionaire-Fueled Backlash
Treasury Secretary Scott Bessent, under pressure from President Trump and tech billionaires including Elon Musk and Mark Zuckerberg who sought to limit the agency's power, ordered a halt to the Consumer Financial Protection Bureau's operations on Monday.
Progress
64% Bias Score
1.1 Million Miss UK Tax Deadline, Facing Penalties
Approximately 1.1 million UK taxpayers missed the January 31st, 2024 tax filing deadline, incurring at least a £100 penalty, while over 11.5 million others filed successfully, with 31,000 completing their returns within the final hour; new rules require online platforms to share sales data with HMRC...
1.1 Million Miss UK Tax Deadline, Facing Penalties
Approximately 1.1 million UK taxpayers missed the January 31st, 2024 tax filing deadline, incurring at least a £100 penalty, while over 11.5 million others filed successfully, with 31,000 completing their returns within the final hour; new rules require online platforms to share sales data with HMRC...
Progress
36% Bias Score
Franklin Templeton Launches Innovative Dividend ETFs with Higher Projected Yields
Franklin Templeton launched two new dividend ETFs, XUDV and XDIV, in late January, offering higher projected dividend yields (4.13% and 7.43%, respectively) than many competitors through custom indexes designed to balance yield and risk, while maintaining competitive fees and contrasting with other ...
Franklin Templeton Launches Innovative Dividend ETFs with Higher Projected Yields
Franklin Templeton launched two new dividend ETFs, XUDV and XDIV, in late January, offering higher projected dividend yields (4.13% and 7.43%, respectively) than many competitors through custom indexes designed to balance yield and risk, while maintaining competitive fees and contrasting with other ...
Progress
40% Bias Score
Novartis Reports Record 2024 Sales Despite Morphosys Write-Down
Novartis announced record 2024 financial results: \$50.3 billion in sales (up 11%), \$19.5 billion in operating core earnings (up 19%), and \$11.9 billion in net income (up 39%), driven by innovative medicines; however, a \$900 million write-down from the Morphosys acquisition impacted the results.
Novartis Reports Record 2024 Sales Despite Morphosys Write-Down
Novartis announced record 2024 financial results: \$50.3 billion in sales (up 11%), \$19.5 billion in operating core earnings (up 19%), and \$11.9 billion in net income (up 39%), driven by innovative medicines; however, a \$900 million write-down from the Morphosys acquisition impacted the results.
Progress
44% Bias Score
Showing 133 to 144 of 623 results